Literature DB >> 19418563

Kinetic study of beta-amyloid residue accessibility using reductive alkylation and mass spectrometry.

Irina Ramos1, Dan Fabris, Wei Qi, Erik J Fernandez, Theresa A Good.   

Abstract

Beta-amyloid peptide (Abeta) is the major protein constituent found in senile plaques in Alzheimer's disease (AD). It is believed that Abeta plays a role in neurodegeneration associated with AD and that its toxicity is related to its structure or aggregation state. In this study, an approach based on chemical modification of primary amines and mass spectrometric (MS) detection was used to identify residues on Abeta peptide that were exposed or buried upon changes in peptide structure associated with aggregation. Results indicate that the N terminus was the most accessible primary amine in the fibril, followed by lysine 28, then lysine 16. A kinetic analysis of the data was then performed to quantify differences in accessibility between these modification sites. We estimated apparent equilibrium unfolding constants for each modified site of the peptide, and determined that the unfolding constant for the N terminus was approximately 100 times greater than that for K28, which was about six times greater than that for K16. Understanding Abeta peptide structure at the residue level is a first step in designing novel therapies for prevention of Abeta structural transitions and/or cell interactions associated with neurotoxicity in Alzheimer's disease. (c) 2009 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19418563      PMCID: PMC2716430          DOI: 10.1002/bit.22367

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  58 in total

1.  Heterogeneity within MALDI samples as revealed by mass spectrometric imaging.

Authors:  R W Garden; J V Sweedler
Journal:  Anal Chem       Date:  2000-01-01       Impact factor: 6.986

2.  Exposing asymmetry between monomers in Alzheimer's amyloid fibrils via reductive alkylation of lysine residues.

Authors:  K Iwata; S J Eyles; J P Lee
Journal:  J Am Chem Soc       Date:  2001-07-11       Impact factor: 15.419

3.  Unraveling the secrets of Alzheimer's beta-amyloid fibrils.

Authors:  Lynmarie K Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-13       Impact factor: 11.205

4.  Surface structure of amyloid-beta fibrils contributes to cytotoxicity.

Authors:  Yuji Yoshiike; Takumi Akagi; Akihiko Takashima
Journal:  Biochemistry       Date:  2007-08-04       Impact factor: 3.162

5.  Liquid matrix deposition on conductive hydrophobic surfaces for tuning and quantitation in UV-MALDI mass spectrometry.

Authors:  Magnus Palmblad; Rainer Cramer
Journal:  J Am Soc Mass Spectrom       Date:  2007-01-16       Impact factor: 3.109

6.  Binding of amyloid beta-peptide to ganglioside micelles is dependent on histidine-13.

Authors:  Mike P Williamson; Yu Suzuki; Nathan T Bourne; Tetsuo Asakura
Journal:  Biochem J       Date:  2006-08-01       Impact factor: 3.857

7.  Structure of the 21-30 fragment of amyloid beta-protein.

Authors:  Andrij Baumketner; Summer L Bernstein; Thomas Wyttenbach; Noel D Lazo; David B Teplow; Michael T Bowers; Joan-Emma Shea
Journal:  Protein Sci       Date:  2006-06       Impact factor: 6.725

8.  Acceleration of amyloid fibril formation by specific binding of Abeta-(1-40) peptide to ganglioside-containing membrane vesicles.

Authors:  L P Choo-Smith; W Garzon-Rodriguez; C G Glabe; W K Surewicz
Journal:  J Biol Chem       Date:  1997-09-12       Impact factor: 5.157

9.  Oxidation of methionine residues in recombinant human interleukin-1 receptor antagonist: implications of conformational stability on protein oxidation kinetics.

Authors:  Renuka Thirumangalathu; Sampathkumar Krishnan; Pavel Bondarenko; Margaret Speed-Ricci; Theodore W Randolph; John F Carpenter; David N Brems
Journal:  Biochemistry       Date:  2007-05-05       Impact factor: 3.162

10.  Direct quantitative analysis of peptides using matrix assisted laser desorption ionization.

Authors:  A I Gusev; W R Wilkinson; A Proctor; D M Hercules
Journal:  Anal Bioanal Chem       Date:  1996-02       Impact factor: 4.142

View more
  4 in total

Review 1.  Biochemistry of amyloid β-protein and amyloid deposits in Alzheimer disease.

Authors:  Colin L Masters; Dennis J Selkoe
Journal:  Cold Spring Harb Perspect Med       Date:  2012-06       Impact factor: 6.915

2.  Beta-amyloid auto-antibodies are reduced in Alzheimer's disease.

Authors:  Bao-Xi Qu; Yunhua Gong; Carol Moore; Min Fu; Dwight C German; Ling-Yu Chang; Roger Rosenberg; Ramon Diaz-Arrastia
Journal:  J Neuroimmunol       Date:  2014-06-27       Impact factor: 3.478

3.  Structurally distinct toxicity inhibitors bind at common loci on β-amyloid fibril.

Authors:  Ben Keshet; Jeffrey J Gray; Theresa A Good
Journal:  Protein Sci       Date:  2010-12       Impact factor: 6.725

4.  Protein Footprinting via Covalent Protein Painting Reveals Structural Changes of the Proteome in Alzheimer's Disease.

Authors:  Casimir Bamberger; Sandra Pankow; Salvador Martínez-Bartolomé; Michelle Ma; Jolene Diedrich; Robert A Rissman; John R Yates
Journal:  J Proteome Res       Date:  2021-04-19       Impact factor: 4.466

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.